rs773675555
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_000179.3(MSH6):c.3946G>A(p.Gly1316Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000179.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.G1316R pathogenic mutation (also known as c.3946G>A), located in coding exon 9 of the MSH6 gene, results from a G to A substitution at nucleotide position 3946. The glycine at codon 1316 is replaced by arginine, an amino acid with dissimilar properties. This variant has been identified in the homozygous state in an individual who met clinical criteria for MSH6-related constitutional mismatch repair deficiency (Bakry D et al. Eur J Cancer, 2014 Mar;50:987-96; Shuen AY et al. J Clin Oncol, 2019 Feb;37:461-470). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this variant is interpreted as a disease-causing mutation. -
Carcinoma of colon Uncertain:1
The p.Gly1316Arg variant has not been reported in the literature nor previously identified by our laboratory. The p.Gly1316 residue is conserved in mammals, but not in lower organisms such as invertebrates. Computational analyses including PolyPhen2 and SIFT suggest the variant may impact the protein product. However, AlignGVGD predicts a more benign role for the variant. However, these prediction tools are not very predictive of pathogenicity. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of unknown significance. -
not provided Uncertain:1
The MSH6 c.3946G>A (p.Gly1316Arg) variant has been reported in the published literature in a homozygous state in an individual with Constitutional mismatch repair deficiency (CMMRD) (PMID: 24440087 (2014)). The frequency of this variant in the general population, 0.000004 (1/249530 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is damaging. Based on the available information, we are unable to determine the clinical significance of this variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at